Position in NBP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$588,471
+$432,161 QoQ
Shares Held
301,780
+374.9% QoQ
Ownership
0.261%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 49 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. NBP ranks #285 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
5,450,825 | $1,020,369,609 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
17,466,641 | $618,144,423 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
3,399,221 | $416,676,508 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
712,259 | $353,800,411 | |
| 5 | MRNA |
Moderna, Inc.
|
4,463,211 | $312,558,664 | |
| 6 | INSM |
INSMED Inc
|
2,584,446 | $275,553,630 | |
| 7 | ABVX |
Abivax S.A.
|
1,844,918 | $245,853,771 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
401,708 | $215,697,109 |
All Filings in NBP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $588,471 | 301,780 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $156,310 | 63,541 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $723,468 | 181,776 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $1,115,394 | 295,078 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $447,324 | 184,845 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $262,481 | 318,546 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $87,595 | 103,054 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $20,898 | 12,514 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $2,475 | 1,331 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $29,030 | 15,279 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $737,289 | 558,553 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $1,607,600 | 537,659 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,837,930 | 531,194 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,271,712 | 543,472 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $444,368 | 110,815 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,476,496 | 219,159 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,660,393 | 102,241 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,348,766 | 70,664 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,835,951 | 94,302 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,270,996 | 169,994 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $31,990 | 660 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $28,101 | 596 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $857,074 | 18,224 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $25,805 | 1,985 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||